KUDOS PHARMACEUTICALS LIMITED - Profile & Financials

Accounts Submitted 7 Aug 2025

Confirmation Statement Submitted 13 Dec 2024

Net assets £1658.00M £634.00M 2024 year on year

Total assets £1886.00M £663.00M 2024 year on year

Total Liabilities £228.00M £29.00M 2024 year on year

Charges 2

2 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom

Office ()

Cambridge, Cambridgeshire, United Kingdom, Europe

Website

kudospharma.co.uk

Credit Report

Discover KUDOS PHARMACEUTICALS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£1658.00M

Increased by £634.00M (+62%)

Total Liabilities

£228.00M

Increased by £29.00M (+15%)

Turnover

£980.00M

Increased by £310.00M (+46%)

Employees

N/A

Debt Ratio

12%

Decreased by 4 (-25%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

8 active 30 resigned

Show resigned officers

						Status
Aradhana Sarin	Director	American	United States	51	28 Jun 2024	Active
Camilla Jane Johnstone	Secretary	Unknown	Unknown	—	16 Sept 2019	Active
Christine Stephens	Director	British	England	54	28 Jun 2024	Active
Hannah Victoria Tattersall	Director	British	England	38	1 May 2025	Active
Iain Alistair Collins	Director	British	United Kingdom	55	31 May 2017	Active
Matthew Shaun Bowden	Director	British	England	48	27 Feb 2019	Active
Sally Sambrook	Director	British	England	53	28 Jun 2024	Active
Susan Galbraith	Director	British	England	60	28 Jun 2024	Active

Shareholders

Shareholders (1)


Astrazeneca Uk Limited	100.0%	6,277,737	Ordinary	18 Dec 2015

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Astrazeneca Uk Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

ASTRAZENECA UK LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

ASTRAZENECA INTERMEDIATE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

ASTRAZENECA PLC united kingdom

KUDOS PHARMACEUTICALS LIMITED Current Company

KUDOS HORSHAM LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

2 satisfied

Documents

Company Filings

Date	Category	Description	Document
7 Aug 2025	Accounts	Annual accounts made up to 2024-12-31	View(27 pages)
2 May 2025	Officers	Appointment of Hannah Victoria Tattersall as director on 2025-05-01	View(2 pages)
1 May 2025	Officers	Termination of Adrian Charles Noel Kemp as director on 2025-05-01	View(1 page)
13 Dec 2024	Confirmation Statement	Confirmation statement made on 2024-12-12 with no updates	View(3 pages)
27 Nov 2024	Resolution	Resolutions	View(3 pages)